Dr Charlott Repschlager is a Volunteer Writer at BioNews and works at the German Federal Institute for Risk Assessment in Berlin. She has completed a PhD at King's College London Institute of Psychiatry, Psychology & Neuroscience. Previously, she has worked as a postdoctoral researcher in cancer at Queen Mary University of London and as a science communications officer. She has studied Human and Medical Science at the University of Westminster..
A routine genetic test used by the NHS to guide prescription of a common chemotherapeutic drug now includes a genetic variant more prevalent in people of African descent...
A large-scale study has unveiled genes essential for early brain development and uncovered the cause of a previously unrecognised neurodevelopmental disorder...
Genetic differences found in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may provide evidence that genetics plays a role in the condition...
The third event in a series looking at large-scale biomedical databases and research resources focused on participant feedback and follow-on...
A genetic test is being investigated to determine whether it can be used to personalise and improve the treatment of a wide variety of NHS patients...
Blood samples have been collected from newborns as Genomics England embarks on its Generation Study...
A genetic mutation known to increase the risk of various cancers, including breast and ovarian cancers, has been linked to infertility in mice...
The downregulation of a normally protective gene drives pancreatic cancer growth and aggressiveness...
How an individual's genetics influences their immune systems' response to sepsis has been investigated by a team of UK researchers...
Mutations in the human genome occur more often than previously expected, but are not deemed harmful, according to a new study...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
